📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Morphogen-IX

1.1 - Company Overview

Morphogen-IX Logo

Morphogen-IX

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Morphogen-IX

Impella Logo

Impella

HQ: Germany Website
  • Description: Provider of minimally invasive cardiovascular support systems for numerous indications in cardiology and coronary surgery. Based in Aachen, Germany, the company develops, manufactures and markets its technology, which is protected by more than 30 European and international patents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Impella company profile →
AngioScore Logo

AngioScore

HQ: United States Website
  • Description: Provider of scoring balloon catheter solutions for coronary and peripheral interventions, including the AngioSculpt Scoring Balloon Catheter that integrates a semi-compliant balloon with an innovative nitinol scoring element to address limitations of conventional angioplasty balloons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AngioScore company profile →
On-X Life Technologies Logo

On-X Life Technologies

HQ: United States Website
  • Description: Provider of mechanical heart valve replacement and cardiac surgery products, developing, manufacturing, and offering artificial heart valve replacement and repair solutions. Portfolio includes On-X Prosthetic Heart Valve; aortic valves with Standard, Conform-X, and Anatomic sewing rings; mitral valves with Standard sewing ring; On-X Ascending Aortic Prosthesis; Chord-X ePTFE sutures, pre-measured loops and adjustable suture system; Chord-X Chordal Sizer; CarbonAid and CarbonMini.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full On-X Life Technologies company profile →
Applied Therapeutics Logo

Applied Therapeutics

HQ: United States Website
  • Description: Provider of drug development targeting molecules/pathways in fatal or debilitating diseases, with programs: govorestat for Galactosemia (pediatric Phase 3 completed; MAA validated; NDA accepted; PDUFA date set), SORD Deficiency (positive pilot; ongoing Phase 3), PMM2-CDG (Phase 2-ready; Expanded Access), AT-001 for Diabetic Cardiomyopathy/Peripheral Neuropathy (Phase 3), and AT-003 for Diabetic Retinopathy (Phase 1-ready).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied Therapeutics company profile →
Kips Bay Medical Logo

Kips Bay Medical

HQ: United States Website
  • Description: Provider of therapeutic vascular technologies for cardiac surgeons.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kips Bay Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Morphogen-IX

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Morphogen-IX

2.2 - Growth funds investing in similar companies to Morphogen-IX

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Morphogen-IX

4.2 - Public trading comparable groups for Morphogen-IX

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Morphogen-IX

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Morphogen-IX

What does Morphogen-IX do?

Morphogen-IX is a provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.

Who are Morphogen-IX's competitors?

Morphogen-IX's competitors and similar companies include Impella, AngioScore, On-X Life Technologies, Applied Therapeutics, and Kips Bay Medical.

Where is Morphogen-IX headquartered?

Morphogen-IX is headquartered in United Kingdom.

How many employees does Morphogen-IX have?

Morphogen-IX has 1,000 employees 🔒.

When was Morphogen-IX founded?

Morphogen-IX was founded in 2010 🔒.

What sector and industry vertical is Morphogen-IX in?

Morphogen-IX is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Morphogen-IX

Who are the top strategic acquirers in Morphogen-IX's sector and industry

Top strategic M&A buyers and acquirers in Morphogen-IX's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Morphogen-IX?

Top strategic M&A buyers groups and sectors for Morphogen-IX include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Morphogen-IX's sector and industry vertical

Which are the top PE firms investing in Morphogen-IX's sector and industry vertical?

Top PE firms investing in Morphogen-IX's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Morphogen-IX's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Morphogen-IX's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Morphogen-IX's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Morphogen-IX include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Morphogen-IX's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Morphogen-IX?

The key public trading comparables and valuation benchmarks for Morphogen-IX include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Morphogen-IX for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Morphogen-IX with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Morphogen-IX's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Morphogen-IX with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Morphogen-IX's' sector and industry vertical?

Access recent funding rounds and capital raises in Morphogen-IX's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Morphogen-IX